​​2020년 졸업생 / 現 순천향 대학교 박사과정

​

학위논문

Circular miR-1307-5p as a potential metastatic marker for hepatocellular carcinoma​

​

발표논문

1. Effect of Fibroblast Growth Factor-2 and its Receptor Gene Polymorphisms on the Survival of Patients With Hepatitis B Virus-associated Hepatocellular Carcinoma. Kim SS, Eun JW, Cho HJ, Lee HY, Seo CW, Noh CK, Shin SJ, Lee KM, Cho SW, Cheong JY. Anticancer Res. 2019 Apr;39(4):2217-2226.

2. Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma. Kim SS, Baek GO, Ahn HR, Sung S, Seo CW, Cho HJ, Nam SW, Cheong JY, Eun JW. Mol Oncol. 2020 Oct;14(10):2646-2659. doi: 10.1002/1878-0261.12745. Epub 2020 Jul 13.

3. Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma. Cho HJ, Eun JW, Baek GO, Seo CW, Ahn HR, Kim SS, Cho SW, Cheong JY. J Clin Med. 2020 Jan 20;9(1):281. doi: 10.3390/jcm9010281.

4. Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma. Cho HJ, Baek GO, Seo CW, Ahn HR, Sung S, Son JA, Kim SS, Cho SW, Jang JW, Nam SW, Cheong JY, Eun JW. Cancer Med. 2020 Aug;9(15):5459-5472. doi: 10.1002/cam4.3230. Epub 2020 Jun 14.

5. Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment. Cho HJ, Kim B, Kim HJ, Huh J, Kim JK, Lee JH, Seo CW, Ahn HR, Eun JW, Kim SS, Cho SW, Cheong JY. Eur Radiol. 2020 Aug;30(8):4182-4192. doi: 10.1007/s00330-020-06792-y. Epub 2020 Mar 18.

6. Circulating Exosomal MicroRNA-1307-5p as a Predictor for Metastasis in Patients with Hepatocellular Carcinoma. Eun JW, Seo CW, Baek GO, Yoon MG, Ahn HR, Son JA, Sung S, Kim DW, Kim SS, Cho HJ, Cheong JY. Cancers (Basel). 2020 Dec 18;12(12):3819. doi: 10.3390/cancers12123819.

7. Bioelectrical impedance analysis for predicting postoperative complications and survival after liver resection for hepatocellular carcinoma. Lee GH, Cho HJ, Lee G, Kim HG, Wang HJ, Kim BW, Lee MY, Yoon SY, Noh CK, Seo CW, Eun JW, Cheong JY, Cho SW, Kim SS. Ann Transl Med. 2021 Feb;9(3):190. doi: 10.21037/atm-20-5194.

2023년 졸업생 / 現 ​㈜유진셀 연구원

​

학위논문

Non-invasive markers of diagnosis and recurrence in patients with hepatocellular carcinoma

발표논문

1. HMBS is the most suitable reference gene for RT-qPCR in human HCC tissues and blood samples. Ahn HR, Baek GO, Yoon MG, Son JA, You D, Yoon JH, Cho HJ, Kim SS, Cheong JY, Eun JW. Oncol Lett. 2021 Nov;22(5):791.​

2. Circulating Exosomal MicroRNA-1307-5p as a Predictor for Metastasis in Patients with Hepatocellular Carcinoma. Eun JW, Seo CW, Baek GO, Yoon MG, Ahn HR, Son JA, Sung S, Kim DW, Kim SS, Cho HJ, Cheong JY. Cancers (Basel). 2020 Dec 18;12(12):3819.

3. Overexpressed Proteins in HCC Cell-Derived Exosomes, CCT8, and Cofilin-1 Are Potential Biomarkers for Patients with HCC. Cho HJ, Baek GO, Yoon MG, Ahn HR, Son JA, Kim SS, Cheong JY, Eun JW. Diagnostics (Basel). 2021 Jul 6;11(7):1221.

4. Early detection of hepatocellular carcinoma via liquid biopsy: panel of small extracellular vesicle-derived long noncoding RNAs identified as markers. Kim SS, Baek GO, Son JA, Ahn HR, Yoon MK, Cho HJ, Yoon JH, Nam SW, Cheong JY, Eun JW. Mol Oncol. 2021 Oct;15(10):2715-2731.

5. Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma. Cho HJ, Baek GO, Seo CW, Ahn HR, Sung S, Son JA, Kim SS, Cho SW, Jang JW, Nam SW, Cheong JY, Eun JW. Cancer Med. 2020 Aug;9(15):5459-5472.

6. Hypomethylation-mediated upregulation of the WASF2 promoter region correlates with poor clinical outcomes in hepatocellular carcinoma. Ahn HR, Baek GO, Yoon MG, Son JA, Yoon JH, Cheong JY, Cho HJ, Kang HC, Eun JW, Kim SS. J Exp Clin Cancer Res. 2022 Apr 28;41(1):158.

7. Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma. Eun JW, Ahn HR, Baek GO, Yoon MG, Son JA, Weon JH, Yoon JH, Kim HS, Han JE, Kim SS, Cheong JY, Kim BW, Cho HJ. Int J Mol Sci. 2023 Feb 21;24(5):4272.

8. Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma. Son JA*, Ahn HR, You D, Baek GO, Yoon MG, Yoon JH, Cho HJ, Kim SS, Nam SW, Eun JW, Cheong JY. Cancers (Basel). 2022 Feb 9;14(4):865. * 1ST AUTHOR

9. Circulating small extracellular vesicle-derived splicing factor 3b subunit 4 as a non-invasive diagnostic biomarker of early hepatocellular carcinoma. Son JA*, Weon JH, Baek GO, Ahn HR, Choi JY, Yoon MG, Cho HJ, Cheong JY, Eun JW, Kim SS. J Exp Clin Cancer Res. 2023 Oct 30;42(1):288. * 1ST AUTHOR

10. Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib. Eun JW, Yoon JH, Ahn HR, Kim S, Kim YB, Lim SB, Park W, Kang TW, Baek GO, Yoon MG, Son JA, Weon JH, Kim SS, Cho HJ, Cheong JY. Cancer Commun (Lond). 2023 Apr;43(4):455-479.